Bank of Montreal
OCUL icon

Bank of Montreal’s Ocular Therapeutix OCUL Stock Holding History

Bank of Montreal’s Portfolio OCUL Stock Details OCUL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-181,509
Closed -$937K – 4105
2023
Q2 		$937K Buy
+181,509
New +$1.08M ﹤0.01% 2227
2022
Q3 		– Sell
-511,195
Closed -$2.16K – 4327
2022
Q2 		$2.16K Buy
511,195
+300,258
+142% +$1.13M ﹤0.01% 1859
2022
Q1 		$1.08M Buy
+210,937
New +$1.17M ﹤0.01% 2275
2021
Q2 		– Sell
-3,397
Closed -$56K – 4545
2021
Q1 		$56K Sell
3,397
-8,265
-71% -$159K ﹤0.01% 3646
2020
Q4 		$252K Buy
11,662
+8,209
+238% +$122K ﹤0.01% 3094
2020
Q3 		$29K Sell
3,453
-1,291
-27% -$10.7K ﹤0.01% 3660
2020
Q2 		$36K Buy
4,744
+4,097
+633% +$27.2K ﹤0.01% 3587
2020
Q1 		$3K Sell
647
-5,329
-89% -$26.3K ﹤0.01% 3788
2019
Q4 		$24K Sell
5,976
-16,407
-73% -$57K ﹤0.01% 4218
2019
Q3 		$68K Buy
22,383
+576
+3% +$2.58K ﹤0.01% 3490
2019
Q2 		$96K Buy
21,807
+21,721
+25,257% +$80.4K ﹤0.01% 3365
2019
Q1 		$0 Sell
86
-394
-82% -$1.58K ﹤0.01% 4612
2018
Q4 		$2K Sell
480
-21,470
-98% -$118K ﹤0.01% 4399
2018
Q3 		$151K Buy
21,950
+2
+0% +$13 ﹤0.01% 2908
2018
Q2 		$149K Sell
21,948
-5,427
-20% -$37.3K ﹤0.01% 2915
2018
Q1 		$178K Buy
27,375
+1,919
+8% +$10.8K ﹤0.01% 2685
2017
Q4 		$113K Sell
25,456
-14,628
-36% -$74.7K ﹤0.01% 2958
2017
Q3 		$247K Buy
40,084
+15,902
+66% +$102K ﹤0.01% 2578
2017
Q2 		$225K Buy
24,182
+2,000
+9% +$19.4K ﹤0.01% 2609
2017
Q1 		$206K Sell
22,182
-1,126
-5% -$9.38K ﹤0.01% 2458
2016
Q4 		$217K Buy
23,308
+23,105
+11,382% +$179K ﹤0.01% 2456
2016
Q3 		$1K Buy
+203
New +$1.24K ﹤0.01% 3940
2016
Q2 		– Sell
-5,000
Closed -$48K – 4254
2016
Q1 		$48K Buy
5,000
+4,264
+579% +$32.3K ﹤0.01% 3063
2015
Q4 		$7K Buy
+736
New +$7.95K ﹤0.01% 3711

Other funds holding OCUL

OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
SR
Summer Road West Palm Beach, Florida $142M AUM 43.61% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DAM
Deltec Asset Management New York $677M AUM 31.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

Bank of Montreal's OCUL Position: Q3 2023 in Review

Bank of Montreal sold out of Ocular Therapeutix (OCUL) in Q3 2023, closing a stake of 181,509 shares — an estimated $937K sold.

Bank of Montreal first reported a position in OCUL in Q4 2015 and held it in 24 quarters. The position peaked at $1.08M in Q1 2022. 113 funds tracked by Wall St. Rank hold OCUL as of Q3 2023.

  • Bank of Montreal reported no remaining Ocular Therapeutix position as of Q3 2023 after selling out during the quarter.
  • Bank of Montreal sold 181,509 Ocular Therapeutix shares in Q3 2023, an estimated $937K.
  • Bank of Montreal first reported a position in Ocular Therapeutix in Q4 2015 and held it in 24 quarters.
  • Bank of Montreal's Ocular Therapeutix position peaked at $1.08M in Q1 2022.
  • 113 funds tracked by Wall St. Rank held Ocular Therapeutix as of Q3 2023.

Based on Bank of Montreal's 13F filing for Q3 2023, filed 1 Nov 2023.